Загрузка...
Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy
Recent advances in cancer biology and genetics have fostered precision therapies targeting tumor-specific attributes. Immune-based therapies that elicit cytolytic T cells (CTL) specific for tumor antigens can provide therapeutic benefit to cancer patients, however, cure rates are typically low. This...
Сохранить в:
| Опубликовано в: : | Immunotherapy |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Future Medicine Ltd
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5619014/ https://ncbi.nlm.nih.gov/pubmed/28000531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2016-0097 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|